DETERMINATION OF NITRAZEPAM AND ITS MAIN METABOLITES IN URINE BY GAS-LIQUID CHROMATOGRAPHY: USE OF ELECTRON CAPTURE AND NITROGEN-SELECTIVE DETECTORSKANGAS L.1979; J. CHROMATOGR.; NLD; DA. 1979; VOL. 172; PP. 273-278; BIBL. 16 REF.Article

COMPARISON OF TWO GAS-LIQUID CHROMATOGRAPHIC METHODS FOR THE DETERMINATION OF NITRAZEPANI IN PLASMA.KANGAS L.1977; J. CHROMATOGR.; NETHERL.; DA. 1977; VOL. 136; NO 2; PP. 259-270; BIBL. 29 REF.Article

URINARY ELIMINATION OF NITRAZEPAM AND ITS MAIN METABOLITESKANGAS L.1979; ACTA PHARMACOL. TOXICOL.; DNK; DA. 1979; VOL. 45; NO 1; PP. 16-19; BIBL. 5 REF.Article

Introduction to toremifeneKANGAS, L.Breast cancer research and treatment. 1990, Vol 16, pp S3-S7, issn 0167-6806, SUPConference Paper

STIMULATION OF RENAL TUBULAR TRANSPORT BY ETHACRYNIC ACID IN RATS OF DIFFERENT AGESBRAEUNLICH H; KANGAS L.1979; ACTA PHYSIOL. ACAD. SCI. PHYSIOL.; HUN; DA. 1979; VOL. 53; NO 1; PP. 105-110; ABS. RUS; BIBL. 13 REF.Article

Review of the pharmacological properties of toremifeneKANGAS, L.Journal of steroid biochemistry. 1990, Vol 36, Num 3, pp 191-195, issn 0022-4731, 5 p.Conference Paper

UNCHANGED PROTEIN BINDING AND THE INCREASE OF SERUM DIAZEPAM LEVELS AFTER FOOD INTAKE.KORTTILA K; KANGAS L.1977; ACTA PHARMACOL. TOXICOL.; DANEM.; DA. 1977; VOL. 40; NO 2; PP. 241-246; BIBL. 13 REF.Article

Agonistic and antagonistic effects of antiestrogens in different target organsKANGAS, L.Acta oncologica (Stockholm). 1992, Vol 31, Num 2, pp 141-146, issn 0284-186XConference Paper

Biochemical and pharmacological effects of toremifene metabolitesKANGAS, L.Cancer chemotherapy and pharmacology. 1990, Vol 27, Num 1, pp 8-12, issn 0344-5704, 5 p.Article

CLINICAL PHARMACOKINETICS OF NITRAZEPAMKANGAS L; BREIMER DD.1981; CLIN. PHARMAKINET.; ISSN 0312-5963; AUS; DA. 1981; VOL. 6; NO 5; PP. 346-366; BIBL. 4 P.Article

A COMPARATIVE STUDY OF THE CLINICAL EFFECTS OF PENTOBARBITAL AND DIAZEPAM GIVEN ORALLY AS PREOPERATIVE MEDICATIONHOVI VIANDER M; KANGAS L; KANTO J et al.1980; J. ORAL SURG.; USA; DA. 1980; VOL. 38; NO 3; PP. 188-190; BIBL. 13 REF.Article

CEREBROSPINAL-FLUID CONCENTRATIONS OF DIAZEPAM AND ITS METABOLITES IN MAN = CONCENTRATIONS DANS LE LIQUIDE CEPHALORACHIDIEN DU DIAZEPAM ET DE SES METABOLITES CHEZ L'HOMMEKANTO J; KANGAS L; SIIRTOLA T et al.1975; ACTA PHARMACOL. TOXICOL.; DANEM.; DA. 1975; VOL. 36; NO 4; PP. 328-334; BIBL. 1P.Article

A COMPARATIVE STUDY ON THE CLINICAL EFFECTS OF FLUNITRAZEPAM AND LORAZEPAMMANSIKKA M; KANGAS L; KANTO J et al.1980; INT. J. CLIN. PHARMACOL. THER. TOXICOL.; DEU; DA. 1980; VOL. 18; NO 7; PP. 320-321; BIBL. 7 REF.Article

PLASMA NITRAZEPAM CONCENTRATIONS AFTER AN ACUTE INTAKE AND THEIR CORRELATION TO SEDATION AND SERUM GROWTH HORMONE LEVELS.KANGAS L; KANTO J; SYVALAHTI E et al.1977; ACTA PHARMACOL. TOXICOL.; DANEM.; DA. 1977; VOL. 41; NO 1; PP. 65-73; BIBL. 13 REF.Article

A PHARMACOKINETIC AND PHARMACODYNAMIC STUDY OF FLUNITRAZEPAMKANGAS L; KANTO J; PAKKANEN A et al.1982; INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY, THERAPY AND TOXICOLOGY (1980); ISSN 506508; DEU; DA. 1982; VOL. 20; NO 12; PP. 585-588; BIBL. 22 REF.Article

A COMPARATIVE STUDY ON THE CLINICAL EFFECTS OF FLUNITRAZEPAM AND OXAZEPAM AS ORAL PREMEDICATIONPAKKANEN A; KANGAS L; KANTO J et al.1981; INT. J. CLIN. PHARMACOL. THER. TOXICOL.; DEU; DA. 1981; VOL. 19; NO 6; PP. 275-278; BIBL. 23 REF.Article

FLUNITRAZEPAM VERSUS PLACEBO PREMEDICATION FOR MINOR SURGERYKANTO J; KANGAS L; MANSIKKA M et al.1979; ACTA ANAESTHESIOL. SCAND.; DNK; DA. 1979; VOL. 23; NO 6; PP. 561-566; BIBL. 16 REF.Article

THE PHARMACOKINETICS OF DAPSONE AND ACETYLATED DAPSONE IN SERUM AND SALIVALAMMINTAUSTA K; KANGAS L; LAMMINTAUSTA R et al.1979; INTERNATION. J. CLIN. PHARMACOL. BIOPHARM.; DEU; DA. 1979; VOL. 17; NO 4; PP. 159-163; BIBL. 23 REF.Article

TRANSFER OF NITRAZEPAM ACROSS THE HUMAN PLACENTA.KANGAS L; KANTO J; ERKKOLA R et al.1977; EUROP. J. CLIN. PHARMACOL.; GERM.; DA. 1977; VOL. 12; NO 5; PP. 355-357; BIBL. 13 REF.Article

THE TRANSFER OF DIAZEPAM ACROSS THE PLACENTA DURING LABOURERKKOLA R; KANGAS L; PEKKARINEN A et al.1973; ACTA OBSTETR. GYNECOL. SCAND.; SUEDE; DA. 1973; VOL. 52; NO 2; PP. 167-170; BIBL. 16 REF.Article

COMPARISON OF OLD AND NEW TYPES OF PREMEDICATIONSKANTO J; PAKKANEN A; KANGAS L et al.1982; INT. J. CLIN. PHARMACOL. THER. TOXICOL.; DEU; DA. 1982; VOL. 20; NO 4; PP. 187-189; BIBL. 11 REF.Article

FLUNITRAZEPAM AS AN INDUCTION AGENT IN ELDERLY, POOR-RISK PATIENTSHOVI VIANDER M; AALTONEN L; KANGAS L et al.1982; ACTA ANAESTHESIOL. SCAND.; ISSN 0001-5172; DNK; DA. 1982; VOL. 26; NO 5; PP. 507-510; BIBL. 14 REF.Article

TOFIZOPAM: A BENZODIAZEPINE DERIVATIVE WITHOUT SEDATIVE EFFECTKANTO J; KANGAS L; LEPPAENEN T et al.1982; INT. J. CLIN. PHARMACOL. THER. TOXICOL.; ISSN 506508; DEU; DA. 1982; VOL. 20; NO 7; PP. 309-312; BIBL. 12 REF.Article

THE PROTEIN BINDING OF DIAZEPAM AND N-DEMETHYLDIAZEPAM IN PATIENTS WITH POOR RENAL FUNCTIONKANGAS L; KANTO J; FORSSTROM J et al.1976; CLIN. NEPHROL.; GERM.; DA. 1976; VOL. 5; NO 3; PP. 114-118; ABS. FR. ALLEM.; BIBL. 21 REF.Article

REDUCED CONCENTRATIONS OF PLASMA DIAZEPAM IN CHRONIC ALCOHOLIC PATIENTS FOLLOWING ON ORAL ADMINISTRATION OF DIAZEPAM = CONCENTRATIONS PLASMATIQUES REDUITES DE DIAZEPAM CHEZ DES MALADES ALCOOLIQUES CHRONIQUES APRES ADMINISTRATION D'UNE DOSE DE DIAZEPAM PER OSSELLMAN R; PEKKARINEN A; KANGAS L et al.1975; ACTA PHARMACOL. TOXICOL.; DANEM.; DA. 1975; VOL. 36; NO 1; PP. 25-32; BIBL. 14REF.Article